Earnings History Data for Akebia Therapeutics, Inc. (AKBA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Akebia Therapeutics, Inc.

Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-03-2023 PM Before the open
(Mar 9)		 AKBA Akebia Therapeutics, Inc. 127.28 -0.04 0.00 -0.40 Akebia GAAP EPS of -$0.04 beats by $0.15, revenue of $55.18M beats by $7.78M
[3/9/2023 7:42 AM]		 0.8013 -0.23 
(-22.20%)		 0.84 -0.19 
(-18.45%)		 0.24 - 2.93 5,701,206 2,690,000 1,133,224
03-11-2022 AH 4:05 PM ET
(Nov 3)		 AKBA Akebia Therapeutics, Inc. 49.82 -0.28 -0.14 -0.34 Akebia reports mixed Q3 earnings; reaffirms FY22 Auryxia net product revenue guidance
[11/3/2022 4:35 PM]		 0.2760 -0.01 
(-3.19%)		 0.27 -0.02 
(-5.30%)		 0.24 - 3.30 1,423,893 1,250,000 196,709
04-08-2022 AH 4:05 PM ET
(Aug 4)		 AKBA Akebia Therapeutics, Inc. 78.00 0.23 -0.29 -0.51 Akebia GAAP EPS of $0.15 beats by $0.48, revenue of $126.76M beats by $77.06M
[8/4/2022 4:19 PM]		 0.3950 -0.02 
(-3.66%)		 0.39 -0.02 
(-4.51%)		 0.30 - 3.35 6,038,127 4,470,000 670,291
09-05-2022 AH 4:00 PM ET
(May 9)		 AKBA Akebia Therapeutics, Inc. 75.96 -0.35 -0.27 -0.45 Akebia GAAP EPS of -$0.35 misses by $0.06, revenue of $61.7M beats by $17.48M
[5/9/2022 4:20 PM]		 0.4151 0.07 
(20.18%)		 0.38 0.03 
(10.05%)		 0.34 - 4.33 13,817,855 10,395,840 228,249
04-11-2021 PM 8:00 AM ET
(Nov 4)		 AKBA Akebia Therapeutics, Inc. 546.30 -0.34 -0.32 -0.42 Akebia EPS misses by $0.03, misses on revenue
[11/4/2021 8:08 AM]		 3.04 -0.30 
(-8.98%)		 3.04 0.0 
(0.00%)		 2.30 - 5.14 2,697,636 2,030,000 2,014
05-08-2021 PM 8:00 AM ET
(Aug 5)		 AKBA Akebia Therapeutics, Inc. 395.48 -0.51 -0.30 -0.44 Akebia EPS misses by $0.20, revenue in-line
[8/5/2021 8:03 AM]		 2.86 0.38 
(15.12%)		 2.44 -0.04 
(-1.61%)		 2.09 - 11.57 5,235,651 3,740,000 47,857
10-05-2021 PM 8:00 AM ET
(May 10)		 AKBA Akebia Therapeutics, Inc. 508.51 -0.45 -0.33 -0.47 Akebia EPS misses by $0.08, beats on revenue
[5/10/2021 8:06 AM]		 2.90 -0.21 
(-6.89%)		 3.08 -0.04 
(-1.28%)		 2.09 - 13.71 3,553,865 3,050,000 29,807
25-02-2021 PM 8:00 AM ET
(Feb 25)		 AKBA Akebia Therapeutics, Inc. 641.75 -0.60 -0.43 -0.61 Akebia EPS misses by $0.22, beats on revenue
[2/25/2021 8:02 AM]		 3.46 -0.82 
(-19.16%)		 3.86 -0.42 
(-9.81%)		 2.09 - 13.71 13,605,442 6,865,401 710,398
05-11-2020 PM 7:00 AM ET
(Nov 5)		 AKBA Akebia Therapeutics, Inc. 346.83 -0.42 -0.23 -0.28 Akebia EPS misses by $0.19, misses on revenue
[11/5/2020 8:06 AM]		 2.49 -0.08 
(-3.11%)		 2.49 0.0 
(0.00%)		 2.09 - 13.71 8,357,554 10,997,197 4,740
10-08-2020 PM 7:00 AM ET
(Aug 10)		 AKBA Akebia Therapeutics, Inc. 1,580 -0.44 -0.46 -0.30 10.70 -0.28 
(-2.55%)		 10.98 0.0 
(0.00%)		 2.99 - 13.71 400,360 924,009 32,444
05-05-2020 PM 7:50 AM ET
(May 5)		 AKBA Akebia Therapeutics, Inc. 1,040 -0.47 -0.63 -0.44 Akebia EPS beats by $0.16, beats on revenue
[5/5/2020 7:41 AM]		 11.85 3.19 
(36.84%)		 10.29 1.63 
(18.82%)		 2.99 - 12.02 6,325,513 870,332 454,965